3.238.204.31
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Lupus Nephritis

Renal response achieved with add-on belimumab in patients with LN in real-life setting

Among the 91 patients with lupus glomerulonephritis who received add-on belimumab in a real-life setting who met the study criteria, 70.3% (n = 64) achieved primary efficacy renal response (PERR), of which 38.4% achieved complete renal response during a median follow-up period of 22 months. The majority (86.7%) of patients...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-